APPLICATION OF CURCUMINOIDS-LOADED NANOEMULSION FOR CANCER THERAPY

E. Coelho, Francisco Célio Feitosa De França, Louhana Moreira Rebouças, A. Uchoa, Luana De Morais Semião, Deyse De Sousa Maia, D. Moreira, D. Pinheiro, Larissa Morais Ribeiro da Silva, C. Pessoa, M. E. Ribeiro, N. Ricardo
{"title":"APPLICATION OF CURCUMINOIDS-LOADED NANOEMULSION FOR CANCER THERAPY","authors":"E. Coelho, Francisco Célio Feitosa De França, Louhana Moreira Rebouças, A. Uchoa, Luana De Morais Semião, Deyse De Sousa Maia, D. Moreira, D. Pinheiro, Larissa Morais Ribeiro da Silva, C. Pessoa, M. E. Ribeiro, N. Ricardo","doi":"10.31069/japsrv5i3.04","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: Curcuminoids and Oleic acid, reported in the literature as antioxidant and antitumor agents, were combined in nanoemulsion, using Pluronic F127 as a stabilizer. \nMETHODS: The main objective is to investigate its cytotoxic activity against cancer cells. \nRESULTS AND DISCUSSION: The nanoemulsion show values of the particle size (251.4 ± 4.6 nm), zeta potential (-34.8 ± 1.0 mV), and pH (4.8) classifying it as stable and non-irritating for pharmacological applications. The main results indicate that, in the toxicity test in fish (Zebrafish), the nanoformulation proved to be biosafe and the evaluation of the antioxidant action (by DPPH) showed excellent antioxidant activity. Furthermore, in the vitro cytotoxicity studies, the nanoemulsions showed good cytotoxic activity, ideal for fighting Colorectal, Glioblastoma, and Leukemia cancers and more effectively in Prostate cancer. ","PeriodicalId":13749,"journal":{"name":"INTERNATIONAL JOURNAL OF APPLIED PHARMACEUTICAL SCIENCES AND RESEARCH","volume":"96 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INTERNATIONAL JOURNAL OF APPLIED PHARMACEUTICAL SCIENCES AND RESEARCH","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31069/japsrv5i3.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION: Curcuminoids and Oleic acid, reported in the literature as antioxidant and antitumor agents, were combined in nanoemulsion, using Pluronic F127 as a stabilizer. METHODS: The main objective is to investigate its cytotoxic activity against cancer cells. RESULTS AND DISCUSSION: The nanoemulsion show values of the particle size (251.4 ± 4.6 nm), zeta potential (-34.8 ± 1.0 mV), and pH (4.8) classifying it as stable and non-irritating for pharmacological applications. The main results indicate that, in the toxicity test in fish (Zebrafish), the nanoformulation proved to be biosafe and the evaluation of the antioxidant action (by DPPH) showed excellent antioxidant activity. Furthermore, in the vitro cytotoxicity studies, the nanoemulsions showed good cytotoxic activity, ideal for fighting Colorectal, Glioblastoma, and Leukemia cancers and more effectively in Prostate cancer. 
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
姜黄素纳米乳在肿瘤治疗中的应用
介绍:以Pluronic F127为稳定剂,将姜黄素和油酸作为抗氧化剂和抗肿瘤剂组合成纳米乳。方法:主要目的是研究其对癌细胞的细胞毒活性。结果和讨论:纳米乳的粒径(251.4±4.6 nm)、zeta电位(-34.8±1.0 mV)和pH(4.8)表明其稳定且无刺激性,可用于药理应用。主要结果表明,在鱼类(斑马鱼)的毒性试验中,纳米制剂被证明是生物安全的,抗氧化作用(DPPH)评价显示出良好的抗氧化活性。此外,在体外细胞毒性研究中,纳米乳液显示出良好的细胞毒性活性,是治疗结直肠癌、胶质母细胞瘤和白血病的理想选择,对前列腺癌更有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PREPARATION OF MICROCRYSTALLINE CELLULOSE FROM DISSOLVING CELLULOSE OBTAINED FROM JUTE FIBERS AND ITS APPLICATION IN THE FORMULATION OF FEXOFENADINE HYDROCHLORIDE TABLET DOSAGE FORM FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF LEVOCETIRIZINE DIHYDROCHLORIDE AND MONTELUKAST SODIUM IN-SILICO DOCKING STUDIES OF CARBONIC ANHYDRASE INHIBITORS IN THE MANAGEMENT OF NEUROPATHIC PAIN PREVALENCE AND ASSOCIATED FACTORS OF ANEMIA AMONG UNDER FIVE YEARS OLD CHILDREN WHO ATTENDED SPINGHAR MOMAND CURATIVE AND TEACHING HOSPITAL, JALALABAD CITY TRASTUZUMAB DERUXTECAN: NOVEL ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN PATIENTS WITH GASTRIC ADENOCARCINOMA
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1